Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for breast density reduction in premenopausal overweight or obese women
ChiCTR1900026211Phase 4Not yet recruiting
- Sponsor
- Chongqing University Cancer Hospital
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metformin in breast cancer (2 arms), sponsored by Chongqing University Cancer Hospital. Primary endpoints: Breast density and Adiponectin. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR1900026211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026211.